Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC)
Titel:
Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC)
Auteur:
Mesnage, S.J.L. Auguste, A. Genestie, C. Dunant, A. Pain, E. Drusch, F. Gouy, S. Morice, P. Bentivegna, E. Lhomme, C. Pautier, P. Michels, J. Le Formal, A. Cheaib, B. Adam, J. Leary, A.F.